Hofseth BioCare aktie (HBC)

Hofseth Biocare ASA: AECORBIO SECURES A FURTHER $1.5M AT A $30M VALUATION FOR ONGOING FT-002A PEPTIDE DEVELOPMENT IN PROSTATE CANCER

Hofseth Biocare ASA: AECORBIO SECURES A FURTHER $1.

Hofseth Biocare ASA: ProGo, the world’s first consumer health GLP-1 & GIP receptor agonist with muscle mass protection via inhibition of Myostatin and Activin A pathways

Hofseth Biocare ASA: ProGo, the world’s first consumer health GLP-1 & GIP receptor agonist with muscle mass protection via inhibition of Myo...

GlobeNewswire • 09 Sep 08:58

Hofseth Biocare ASA: HBC onboards former Head of Nestle Health Science Asia, Oceania, Middle East and Africa Region, Paul Bruhn

GlobeNewswire • 04 Sep 11:36

Hofseth Biocare ASA: SECOND QUARTER 2025 FINANCIAL REPORT

GlobeNewswire • 22 Aug 08:00

Hofseth Biocare ASA: HBC’s ProGo® has won Ingredient of the Year for Healthy Aging at the prestigious Nutraingredients USA awards ceremony in Chicago

Hofseth Biocare ASA: HBC’s ProGo® has won Ingredient of the Year for Healthy Aging at the prestigious Nutraingredients USA awards ceremony i...

GlobeNewswire • 16 Jul 08:00

Hofseth Biocare ASA: Annual General Meeting completed

GlobeNewswire • 23 May 14:50

Hofseth Biocare ASA: FIRST QUARTER 2025 FINANCIAL REPORT

GlobeNewswire • 16 May 08:30

Hofseth Biocare ASA: NESTLÉ GARDEN OF LIFE LAUNCHES HBC OMEGO® FULL SPECTRUM OMEGAS IN THE US

GlobeNewswire • 05 May 14:19

Hofseth Biocare ASA: SUCCESSFUL PLACEMENT OF NEW CHF-DENOMINATED UNSECURED BONDS

GlobeNewswire • 05 May 09:00

Hofseth Biocare ASA: HBC ACCELERATES IN HUMAN HEALTH AND PET NUTRITION THROUGH A STRATEGIC PARTNERSHIP WITH SYMRISE TO BUILD OUT BERKÅK, TRIPLING THE MANUFACTURING CAPACITY OF THE GROUP

Hofseth Biocare ASA: HBC ACCELERATES IN HUMAN HEALTH AND PET NUTRITION THROUGH A STRATEGIC PARTNERSHIP WITH SYMRISE TO BUILD OUT BERKÅK, TRI...

GlobeNewswire • 21 Feb 08:30

Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION

GlobeNewswire • 20 Feb 18:19

Hofseth Biocare ASA: FOURTH QUARTER & FULL YEAR 2024 FINANCIAL REPORT

GlobeNewswire • 14 Feb 08:45

Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION

GlobeNewswire • 12 Dec 2024 15:07

Hofseth Biocare ASA: Commences the project for a second hydrolysis plant in Norway to triple capacity

GlobeNewswire • 05 Dec 2024 09:00

Hofseth Biocare ASA: THIRD QUARTER 2024 FINANCIAL REPORT

GlobeNewswire • 08 Nov 2024 08:15

Hofseth Biocare ASA: CFO RESIGNATION

GlobeNewswire • 22 Oct 2024 10:56

Hofseth Biocare ASA: HBC IMMUNOLOGY COMPLETES IN VIVO DRUG LEAD STUDIES FOR PROSTATE CANCER TREATMENT

GlobeNewswire • 08 Oct 2024 08:45

Hofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORT

GlobeNewswire • 23 Aug 2024 08:00

Hofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE’S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERY

GlobeNewswire • 14 Aug 2024 13:09

Hofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc.

GlobeNewswire • 02 Jul 2024 09:00

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

GlobeNewswire • 11 Jun 2024 09:00

Hofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORT

GlobeNewswire • 16 May 2024 08:00

Hofseth Biocare ASA: Annual General Meeting completed

GlobeNewswire • 10 May 2024 14:30

Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024

GlobeNewswire • 19 Apr 2024 13:00

Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING

GlobeNewswire • 05 Apr 2024 18:08

Hofseth Biocare ASA: UPDATED COMPANY PRESENTATION

GlobeNewswire • 21 Mar 2024 10:40

Hofseth Biocare ASA: CHAIR KRISTIN FJELLBY GRUNG STEPS DOWN

GlobeNewswire • 14 Mar 2024 12:12

Hofseth Biocare ASA: FOURTH QUARTER 2023 AND FULL YEAR FINANCIAL REPORT

GlobeNewswire • 09 Feb 2024 08:00

Hofseth Biocare ASA: HBC Immunology Inc successfully completes first animal model of prostate cancer with FT-005 in combination with hormonal (anti-androgen) therapy demonstrating significant anti-tumour activity

Hofseth Biocare ASA: HBC Immunology Inc successfully completes first animal model of prostate cancer with FT-005 in combination with hormona...

GlobeNewswire • 06 Feb 2024 15:56

Hofseth Biocare ASA: SHARE CAPITAL INCREASE REGISTERED

GlobeNewswire • 09 Jan 2024 12:44

Hofseth Biocare ASA: EXTRAORDINARY GENERAL MEETING CONCLUDED

GlobeNewswire • 04 Jan 2024 14:02

Hofseth Biocare ASA: EGM Notice Correction

GlobeNewswire • 15 Dec 2023 11:29

Hofseth Biocare ASA: Notice of an extraordinary general meeting

GlobeNewswire • 14 Dec 2023 13:28

Hofseth Biocare ASA: SIGNIFICANT NEW INVESTMENT OF NOK 144 MILLION FROM HOFSETH INTERNATIONAL INTO HBC

GlobeNewswire • 13 Dec 2023 22:49

Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING

GlobeNewswire • 27 Nov 2023 11:06

Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE

GlobeNewswire • 27 Nov 2023 10:56

Hofseth Biocare ASA: THIRD QUARTER 2023 FINANCIAL REPORT

GlobeNewswire • 10 Nov 2023 08:00

Hofseth Biocare ASA: SECOND QUARTER 2023 FINANCIAL REPORT

GlobeNewswire • 25 Aug 2023 08:00

Hofseth Biocare ASA: SUCCESSFULLY COMPLETED SEED ROUND CAPITAL RAISE IN HBC IMMUNOLOGY LLC AT $20M VALUATION FOR THE DEVELOPMENT OF A NEW PROSTATE CANCER CO-THERAPY

Hofseth Biocare ASA: SUCCESSFULLY COMPLETED SEED ROUND CAPITAL RAISE IN HBC IMMUNOLOGY LLC AT $20M VALUATION FOR THE DEVELOPMENT OF A NEW PR...

GlobeNewswire • 17 Aug 2023 08:58

Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION

GlobeNewswire • 14 Jul 2023 14:33

Hofseth Biocare ASA: ADVANCING THE TREATMENT OF PROSTATE CANCER WITH PUBLICATION OF FTH1 RESEARCH ABSTRACT AHEAD OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) MEETING

Hofseth Biocare ASA: ADVANCING THE TREATMENT OF PROSTATE CANCER WITH PUBLICATION OF FTH1 RESEARCH ABSTRACT AHEAD OF THE AMERICAN SOCIETY OF ...

GlobeNewswire • 30 May 2023 08:40

Hofseth Biocare ASA: SPIN-OFF OF PROSTATE CANCER CO-TREATMENT PROJECT

GlobeNewswire • 15 May 2023 07:50

Hofseth BioCare ASA: FIRST QUARTER 2023 FINANCIAL REPORT

GlobeNewswire • 12 May 2023 07:56

Hofseth Biocare ASA: COMPLETED ANNUAL GENERAL MEETING

GlobeNewswire • 28 Apr 2023 14:09

Hofseth Biocare ASA: DISCLOSURE OF VOTING PROXIES

GlobeNewswire • 28 Apr 2023 11:32

Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2023

GlobeNewswire • 13 Apr 2023 23:56

Hofseth Biocare ASA: HBC ANNUAL REPORT 2022

GlobeNewswire • 31 Mar 2023 08:00

Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION

GlobeNewswire • 17 Feb 2023 08:00

Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION

GlobeNewswire • 15 Feb 2023 18:12

Hofseth Biocare ASA: FOURTH QUARTER 2022 & FULL YEAR FINANCIAL REPORT

GlobeNewswire • 10 Feb 2023 08:00

Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE

GlobeNewswire • 30 Dec 2022 10:08

Hofseth Biocare ASA: THIRD QUARTER 2022 FINANCIAL REPORT

GlobeNewswire • 11 Nov 2022 08:00

Hofseth Biocare ASA: STANFORD SCHOOL OF MEDICINE SUCCESSFULLY COMPLETES PRE-CLINICAL TRIAL WORK TESTING PROGO® BIOACTIVE PEPTIDES IN EFFECTIVE GUT HEALTH SUPPORT

Hofseth Biocare ASA: STANFORD SCHOOL OF MEDICINE SUCCESSFULLY COMPLETES PRE-CLINICAL TRIAL WORK TESTING PROGO® BIOACTIVE PEPTIDES IN EFFECT...

GlobeNewswire • 17 Oct 2022 09:24

Hofseth Biocare ASA: COMPLETED EXTRAORDINARY GENERAL MEETING

GlobeNewswire • 30 Aug 2022 14:25

Hofseth Biocare ASA: HBC’S PROGO BIOACTIVE PEPTIDES NOW IS A “NEW DIETARY INGREDIENT” (NDI) FOR THE US FDA

GlobeNewswire • 29 Aug 2022 08:44

Hofseth Biocare ASA: SECOND QUARTER & H1 2022 FINANCIAL REPORT

GlobeNewswire • 26 Aug 2022 08:00

Hofseth Biocare ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING

GlobeNewswire • 09 Aug 2022 19:30

Hofseth Biocare ASA: SHARE CAPITAL INCREASE REGISTERED

GlobeNewswire • 04 Aug 2022 12:09

Hofseth Biocare ASA: JON OLAV ØDEGÅRD APPOINTED NEW CEO OF HBC

GlobeNewswire • 29 Jul 2022 08:00

Hofseth Biocare ASA: NOTIFIABLE TRANSACTION – REDELIVERY OF SHARES

GlobeNewswire • 18 Jul 2022 11:12

Hofseth Biocare ASA: SHARE CAPITAL INCREASE REGISTERED

GlobeNewswire • 11 Jul 2022 16:24

DISCLOSURE OF LARGE SHAREHOLDING – AQUA-SPARK

GlobeNewswire • 03 Jul 2022 20:45

Hofseth Biocare ASA: NOTIFIABLE TRANSACTIONS IN CONNECTION WITH PRIVATE PLACEMENT

GlobeNewswire • 03 Jul 2022 20:42

Hofseth Biocare ASA: PRIVATE PLACEMENT SUCCESSFULLY PLACED

GlobeNewswire • 03 Jul 2022 20:32

Hofseth Biocare ASA: CONTEMPLATED PRIVATE PLACEMENT

GlobeNewswire • 01 Jul 2022 16:53

Hofseth Biocare ASA: CORRECTION: MANDATORY NOTIFICATION OF TRADE

GlobeNewswire • 06 May 2022 13:34

Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE

GlobeNewswire • 06 May 2022 12:46

Hofseth Biocare ASA: FIRST QUARTER 2022 FINANCIAL REPORT

GlobeNewswire • 06 May 2022 08:00

Hofseth Biocare ASA: APPROVAL OF NEW SHARE INCENTIVE PROGRAM FOR CONSULTANTS – MANDATORY NOTIFICATION OF TRADE

GlobeNewswire • 29 Apr 2022 15:24

Hofseth Biocare ASA: COMPLETED ANNUAL GENERAL MEETING

GlobeNewswire • 29 Apr 2022 15:17

Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2022

GlobeNewswire • 08 Apr 2022 15:49

Hofseth Biocare ASA: HBC ANNUAL REPORT 2021

GlobeNewswire • 25 Mar 2022 16:48

Hofseth Biocare ASA: HOFSETH BIOCARE AWARDED BEST SUSTAINABLE BIOTECH COMPANY 2022 ACCOLADE

GlobeNewswire • 11 Mar 2022 08:00

Hofseth Biocare ASA: HOFSETH BIOCARE SECURES INNOVATION AWARD FOR MEDICAL NUTRITION

GlobeNewswire • 08 Feb 2022 08:00

Hofseth Biocare ASA: FOURTH QUARTER 2021 FINANCIAL REPORT

GlobeNewswire • 04 Feb 2022 07:59

Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE

GlobeNewswire • 22 Dec 2021 14:34

Hofseth Biocare ASA: COMPLETED EXTRAORDINARY GENERAL MEETING

GlobeNewswire • 03 Dec 2021 13:55

Hofseth Biocare ASA: HBC INGREDIENTS SUCCESSFULLY RECEIVE NEW DIETARY INGREDIENT (NDI) STATUS FROM THE US FDA

GlobeNewswire • 02 Dec 2021 08:45

Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE

GlobeNewswire • 18 Nov 2021 14:40

Hofseth Biocare ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING

GlobeNewswire • 08 Nov 2021 17:41

Hofseth Biocare ASA: NEW POTENTIAL PHARMACEUTICAL DRUG LEADS BY HBC

GlobeNewswire • 05 Nov 2021 08:06

Hofseth Biocare ASA: THIRD QUARTER 2021 FINANCIAL REPORT

GlobeNewswire • 05 Nov 2021 08:05

Hofseth Biocare ASA: THE BOARD OF DIRECTORS PROPOSES TO ELECT AMY NOVOGRATZ AS NEW DIRECTOR

GlobeNewswire • 04 Nov 2021 19:32

Hofseth Biocare ASA: AQUA SPARK AS NEW STRATEGIC INVESTOR IN HBC

GlobeNewswire • 04 Nov 2021 16:12

Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER IN HBC

GlobeNewswire • 01 Oct 2021 16:21

Hofseth Biocare ASA: HBC ONBOARDS EX-NOVARTIS AND EX-PFIZER SENIOR REGULATORY AFFAIRS PROFESSIONAL, DR ZUBAIR HUSSAIN

GlobeNewswire • 22 Sep 2021 08:15

Hofseth Biocare ASA: HBC HIRES EX DKSH SENIOR EXECUTIVE DR TANJA SCHAFFER, TO HEAD UP ITS GLOBAL INGREDIENTS BUSINESS AND AS CEO OF HBC SWITZERLAND GMBH

Hofseth Biocare ASA: HBC HIRES EX DKSH SENIOR EXECUTIVE DR TANJA SCHAFFER, TO HEAD UP ITS GLOBAL INGREDIENTS BUSINESS AND AS CEO OF HBC SWIT...

GlobeNewswire • 17 Sep 2021 08:02

Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE

GlobeNewswire • 30 Aug 2021 13:21

Hofseth Biocare ASA: SECOND QUARTER 2021 FINANCIAL REPORT

GlobeNewswire • 27 Aug 2021 08:10

Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION

GlobeNewswire • 25 May 2021 10:22

Hofseth Biocare ASA: FIRST QUARTER 2021 FINANCIAL REPORT

GlobeNewswire • 21 May 2021 08:44

Hofseth Biocare ASA: GLOBAL INNOVATION PARTNERSHIP WITH CATALENT TO DEVELOP DELAYED-RELEASE FORMULATION OF OMEGO FISH OIL

GlobeNewswire • 12 May 2021 08:45

Hofseth Biocare ASA: COMPLETED ANNUAL GENERAL MEETING

GlobeNewswire • 23 Apr 2021 14:03

Hofseth Biocare ASA: IMCD AND HBC EXTEND INTERNATIONAL AGREEMENT TO INCLUDE EUROPE

GlobeNewswire • 15 Apr 2021 08:00

Hofseth BioCare ASA: NOTICE OF ANNUAL GENERAL MEETING 2021

GlobeNewswire • 05 Apr 2021 23:33

Hofseth Biocare ASA: NESTLE-OWNED GARDEN OF LIFE TO LAUNCH NEW PRODUCTS WITH PROGO® IN US RETAIL & ONLINE MARKETS

GlobeNewswire • 31 Mar 2021 08:45

Hofseth Biocare ASA: HBC Annual Report 2020 and ESG Report

GlobeNewswire • 19 Mar 2021 08:14

Pressmeddelanden från Hofseth BioCare

Hofseth Biocare ASA: AECORBIO SECURES A FURTHER $1.5M AT A $30M VALUATION FOR ONGOING FT-002A PEPTIDE DEVELOPMENT IN PROSTATE CANCER

Hofseth Biocare ASA: ProGo, the world’s first consumer health GLP-1 & GIP receptor agonist with muscle mass protection via inhibition of Myostatin and Activin A pathways

Hofseth Biocare ASA: HBC onboards former Head of Nestle Health Science Asia, Oceania, Middle East and Africa Region, Paul Bruhn

Hofseth Biocare ASA: SECOND QUARTER 2025 FINANCIAL REPORT

Hofseth Biocare ASA: HBC’s ProGo® has won Ingredient of the Year for Healthy Aging at the prestigious Nutraingredients USA awards ceremony in Chicago

Hofseth Biocare ASA: Annual General Meeting completed

Hofseth Biocare ASA: FIRST QUARTER 2025 FINANCIAL REPORT

Hofseth Biocare ASA: NESTLÉ GARDEN OF LIFE LAUNCHES HBC OMEGO® FULL SPECTRUM OMEGAS IN THE US

Hofseth Biocare ASA: SUCCESSFUL PLACEMENT OF NEW CHF-DENOMINATED UNSECURED BONDS

Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2025

Hofseth Biocare ASA: HBC ANNUAL REPORT 2024

Hofseth Biocare ASA: CONTEMPLATING UNSECURED BOND ISSUANCE

Hofseth Biocare ASA: HBC ACCELERATES IN HUMAN HEALTH AND PET NUTRITION THROUGH A STRATEGIC PARTNERSHIP WITH SYMRISE TO BUILD OUT BERKÅK, TRIPLING THE MANUFACTURING CAPACITY OF THE GROUP

Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION

Hofseth Biocare ASA: FOURTH QUARTER & FULL YEAR 2024 FINANCIAL REPORT

Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION

Hofseth Biocare ASA: Commences the project for a second hydrolysis plant in Norway to triple capacity

Hofseth Biocare ASA: THIRD QUARTER 2024 FINANCIAL REPORT

Hofseth Biocare ASA: CFO RESIGNATION

Hofseth Biocare ASA: HBC IMMUNOLOGY COMPLETES IN VIVO DRUG LEAD STUDIES FOR PROSTATE CANCER TREATMENT

Hofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORT

Hofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE’S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERY

Hofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc.

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

Hofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORT

Hofseth Biocare ASA: Annual General Meeting completed

Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024

Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING

Hofseth Biocare ASA: UPDATED COMPANY PRESENTATION

Hofseth Biocare ASA: CHAIR KRISTIN FJELLBY GRUNG STEPS DOWN

Hofseth Biocare ASA: FOURTH QUARTER 2023 AND FULL YEAR FINANCIAL REPORT

Hofseth Biocare ASA: HBC Immunology Inc successfully completes first animal model of prostate cancer with FT-005 in combination with hormonal (anti-androgen) therapy demonstrating significant anti-tumour activity

Hofseth Biocare ASA: SHARE CAPITAL INCREASE REGISTERED

Hofseth Biocare ASA: EXTRAORDINARY GENERAL MEETING CONCLUDED

Hofseth Biocare ASA: EGM Notice Correction

Hofseth Biocare ASA: Notice of an extraordinary general meeting

Hofseth Biocare ASA: SIGNIFICANT NEW INVESTMENT OF NOK 144 MILLION FROM HOFSETH INTERNATIONAL INTO HBC

Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING

Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE

Hofseth Biocare ASA: THIRD QUARTER 2023 FINANCIAL REPORT

Hofseth Biocare ASA: SECOND QUARTER 2023 FINANCIAL REPORT

Hofseth Biocare ASA: SUCCESSFULLY COMPLETED SEED ROUND CAPITAL RAISE IN HBC IMMUNOLOGY LLC AT $20M VALUATION FOR THE DEVELOPMENT OF A NEW PROSTATE CANCER CO-THERAPY

Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION

Hofseth Biocare ASA: ADVANCING THE TREATMENT OF PROSTATE CANCER WITH PUBLICATION OF FTH1 RESEARCH ABSTRACT AHEAD OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) MEETING

Hofseth Biocare ASA: SPIN-OFF OF PROSTATE CANCER CO-TREATMENT PROJECT

Hofseth BioCare ASA: FIRST QUARTER 2023 FINANCIAL REPORT

Hofseth Biocare ASA: COMPLETED ANNUAL GENERAL MEETING

Hofseth Biocare ASA: DISCLOSURE OF VOTING PROXIES

Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2023

Hofseth Biocare ASA: HBC ANNUAL REPORT 2022

Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION

Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION

Hofseth Biocare ASA: FOURTH QUARTER 2022 & FULL YEAR FINANCIAL REPORT

Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE

Hofseth Biocare ASA: THIRD QUARTER 2022 FINANCIAL REPORT

Hofseth Biocare ASA: STANFORD SCHOOL OF MEDICINE SUCCESSFULLY COMPLETES PRE-CLINICAL TRIAL WORK TESTING PROGO® BIOACTIVE PEPTIDES IN EFFECTIVE GUT HEALTH SUPPORT

Hofseth Biocare ASA: COMPLETED EXTRAORDINARY GENERAL MEETING

Hofseth Biocare ASA: HBC’S PROGO BIOACTIVE PEPTIDES NOW IS A “NEW DIETARY INGREDIENT” (NDI) FOR THE US FDA

Hofseth Biocare ASA: SECOND QUARTER & H1 2022 FINANCIAL REPORT

Hofseth Biocare ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING

Hofseth Biocare ASA: SHARE CAPITAL INCREASE REGISTERED

Hofseth Biocare ASA: JON OLAV ØDEGÅRD APPOINTED NEW CEO OF HBC

Hofseth Biocare ASA: NOTIFIABLE TRANSACTION – REDELIVERY OF SHARES

Hofseth Biocare ASA: SHARE CAPITAL INCREASE REGISTERED

DISCLOSURE OF LARGE SHAREHOLDING – AQUA-SPARK

Hofseth Biocare ASA: NOTIFIABLE TRANSACTIONS IN CONNECTION WITH PRIVATE PLACEMENT

Hofseth Biocare ASA: PRIVATE PLACEMENT SUCCESSFULLY PLACED

Hofseth Biocare ASA: CONTEMPLATED PRIVATE PLACEMENT

Hofseth Biocare ASA: CORRECTION: MANDATORY NOTIFICATION OF TRADE

Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE

Hofseth Biocare ASA: FIRST QUARTER 2022 FINANCIAL REPORT

Hofseth Biocare ASA: APPROVAL OF NEW SHARE INCENTIVE PROGRAM FOR CONSULTANTS – MANDATORY NOTIFICATION OF TRADE

Hofseth Biocare ASA: COMPLETED ANNUAL GENERAL MEETING

Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2022

Hofseth Biocare ASA: HBC ANNUAL REPORT 2021

Hofseth Biocare ASA: HOFSETH BIOCARE AWARDED BEST SUSTAINABLE BIOTECH COMPANY 2022 ACCOLADE

Hofseth Biocare ASA: HOFSETH BIOCARE SECURES INNOVATION AWARD FOR MEDICAL NUTRITION

Hofseth Biocare ASA: FOURTH QUARTER 2021 FINANCIAL REPORT

Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE